Abstract
Background: Recent research has identified technologies that may be of value in the diagnosis and management of deep vein thrombosis (DVT). We aimed to survey current practice in the United Kingdom (UK) and Australia to determine the extent to which these technologies have been implemented in these two healthcare systems.
Methods: We undertook a postal survey of 255 hospitals in the UK and 89 hospitals in Australia, requesting details of individual diagnostic tests, use of diagnostic algorithms, and management of DVT.
Results: We received replies from 186/255 UK hospitals (73%) and 84/89 of Australian hospitals (94%). Ultrasonography and laboratory based D-dimer were the most commonly available tests. We received 43 different algorithms from 51 hospitals. With only a very few exceptions, DVT diagnosis was ruled in by positive venography or positive ultrasound without venographic confirmation. By contrast a variety of different criteria were used to rule out DVT. Most algorithms used a combination of low clinical risk and negative D-dimer to rule out DVT, but some required all patients to receive ultrasound or venography. Few ruled out on the basis of low clinical risk or negative D-dimer alone. Low molecular weight heparins were overwhelmingly the treatment of choice for established DVT. Most departments (214/264; 81%) offered outpatient treatment.
Conclusion: Recently developed technologies for the diagnosis and treatment of DVT have been widely implemented in the UK and Australia. Variation in practice, and thus presumably uncertainty, seems to be greatest in relation with the criteria used to rule out DVT.
Full Text
The Full Text of this article is available as a PDF (57.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bates Shannon M., Kearon Clive, Crowther Mark, Linkins Lori, O'Donnell Martin, Douketis Jim, Lee Agnes Y. Y., Weitz Jeffrey I., Johnston Marilyn, Ginsberg Jeffrey S. A diagnostic strategy involving a quantitative latex D-dimer assay reliably excludes deep venous thrombosis. Ann Intern Med. 2003 May 20;138(10):787–794. doi: 10.7326/0003-4819-138-10-200305200-00006. [DOI] [PubMed] [Google Scholar]
- Gould M. K., Dembitzer A. D., Doyle R. L., Hastie T. J., Garber A. M. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med. 1999 May 18;130(10):800–809. doi: 10.7326/0003-4819-130-10-199905180-00003. [DOI] [PubMed] [Google Scholar]
- Kearon C., Ginsberg J. S., Douketis J., Crowther M., Brill-Edwards P., Weitz J. I., Hirsh J. Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing. Ann Intern Med. 2001 Jul 17;135(2):108–111. doi: 10.7326/0003-4819-135-2-200107170-00011. [DOI] [PubMed] [Google Scholar]
- Kearon C., Julian J. A., Newman T. E., Ginsberg J. S. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med. 1998 Apr 15;128(8):663–677. doi: 10.7326/0003-4819-128-8-199804150-00011. [DOI] [PubMed] [Google Scholar]
- Kelly James, Rudd Anthony, Lewis Roger R., Hunt Beverley J. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med. 2002 Apr 8;162(7):747–756. doi: 10.1001/archinte.162.7.747. [DOI] [PubMed] [Google Scholar]
- Raftery J. NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ. 2001 Dec 1;323(7324):1300–1303. doi: 10.1136/bmj.323.7324.1300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schutgens R. E. G., Ackermark P., Haas F. J. L. M., Nieuwenhuis H. K., Peltenburg H. G., Pijlman A. H., Pruijm M., Oltmans R., Kelder J. C., Biesma D. H. Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation. 2003 Feb 4;107(4):593–597. doi: 10.1161/01.cir.0000045670.12988.1e. [DOI] [PubMed] [Google Scholar]
- Wells P. S., Anderson D. R., Bormanis J., Guy F., Mitchell M., Gray L., Clement C., Robinson K. S., Lewandowski B. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet. 1997 Dec 20;350(9094):1795–1798. doi: 10.1016/S0140-6736(97)08140-3. [DOI] [PubMed] [Google Scholar]